Articles

If a new finding by Burnham Institute and UCSD scientists holds true, millions of diabetics could someday drastically reduce their dependence on drugs and perhaps even have a cure.

The FDA issued an approvable letter on weight management today for Acomplia (rimonabant), spelling out the steps Sanofi-aventis needs to take to win final approval for its much-heralded diet drug. They do not approve it for smoking-cessation

Encapsulating insulin producing cells in tiny seaweed bubbles and injecting them into people with type 1 diabetes could one day remove the need for daily insulin injections.

Although low-dose thiazide-type diuretics are recommended as initial therapy for most hypertensive patients, chlorthalidone has significantly reduced stroke and cardiovascular end points in several landmark trials. But hydrochlorothiazide remains favored in practice. Most clinicians assume that the drugs are interchangeable, but their antihypertensive effects at lower doses have not been …

Insulin glargine in combination with educational support and close clinical supervision significantly improved metabolic control without significant weight change in patients with Type 2 diabetes.

Research reveals diabetes complications are widespread and growing, and patients desire to gain better control.

Study offers new data and real hope in the battle against amputation.

According to the results of a new study in JAMA, adherence to diet for one year, not the specific diet plan, is the most important determinant of weight loss and reduction of cardiovascular risk.

Transplanting pig islet cells cannot come with a lot of immunosuppression, it must be a very safe treatment.

A Slower Rate of Decline for Peripheral Arterial Disease For Those Patients Who Walk More